BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18459524)

  • 1. Does the relative silicone content of different syringes affect the stability of foam in sclerotherapy?
    Lai SW; Goldman MP
    J Drugs Dermatol; 2008 Apr; 7(4):399-400. PubMed ID: 18459524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Peterson JD; Goldman MP
    Dermatol Surg; 2011 Jan; 37(1):12-7. PubMed ID: 21199095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation on the influence of glycerin on sclerosant foam stability.
    Peterson JD; Goldman MP
    Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commentary: An investigation into the influence of various gases and concentrations of sclerosants on foam stability.
    Frullini A
    Dermatol Surg; 2011 Jan; 37(1):17-8. PubMed ID: 21214662
    [No Abstract]   [Full Text] [Related]  

  • 6. Modified Tessari Tourbillon technique for making foam sclerotherapy with silicone-free syringes.
    Whiteley MS; Patel SB
    Phlebology; 2015 Oct; 30(9):614-7. PubMed ID: 25288590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
    Tessari L; Cavezzi A; Frullini A
    Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of environmental and compositional manipulations on the longevity of Tessari-made foam for sclerotherapy.
    Patel SB; Ostler AE; Dos Santos SJ; Piriea TM; Whiteley MS
    J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):312-8. PubMed ID: 26992311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of coagulation cascade activation and induction of fibrinolysis using foam sclerotherapy of reticular veins.
    Fabi SG; Peterson JD; Goldman MP; Guiha I
    Dermatol Surg; 2012 Mar; 38(3):367-72. PubMed ID: 22092650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium tetradecyl sulfate for sclerotherapy treatment of veins: is compounding pharmacy solution safe?
    Goldman MP
    Dermatol Surg; 2004 Dec; 30(12 Pt 1):1454-6; discussion 1456. PubMed ID: 15606731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New technique in producing sclerosing foam in a disposable syringe.
    Frullini A
    Dermatol Surg; 2000 Jul; 26(7):705-6. PubMed ID: 10886288
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of Syringe Volume on Foam Stability in Sclerotherapy for Varicose Vein Treatment.
    Bai T; Jiang W; Fan Y
    Dermatol Surg; 2018 May; 44(5):689-696. PubMed ID: 29140865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Review of Sclerosing Foam Stability in the Treatment of Varicose Veins.
    Bai T; Liu Y; Jiang W; Li Y; Liu J; Yu C; Fan Y
    Dermatol Surg; 2020 Feb; 46(2):249-257. PubMed ID: 31569112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of polidocanol foam in view of its use in sclerotherapy.
    Nastasa V; Samaras K; Ampatzidis Ch; Karapantsios TD; Trelles MA; Moreno-Moraga J; Smarandache A; Pascu ML
    Int J Pharm; 2015 Jan; 478(2):588-96. PubMed ID: 25433198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foam sclerosants are more stable at lower temperatures.
    Valenzuela GC; Wong K; Connor DE; Behnia M; Parsi K
    Eur J Vasc Endovasc Surg; 2013 Nov; 46(5):593-9. PubMed ID: 24070851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative stability of sodium tetradecyl sulphate (STD) and polidocanol foam: impact on vein damage in an in-vitro model.
    McAree B; Ikponmwosa A; Brockbank K; Abbott C; Homer-Vanniasinkam S; Gough MJ
    Eur J Vasc Endovasc Surg; 2012 Jun; 43(6):721-5. PubMed ID: 22507925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
    VAN Deurzen B; Ceulen RP; Tellings SS; VAN DER Geld C; Nijsten T
    Dermatol Surg; 2011 Oct; 37(10):1448-55. PubMed ID: 21790848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deactivation of sodium tetradecyl sulphate injection by blood proteins.
    Watkins MR
    Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):521-5. PubMed ID: 21262579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Different Mixing Agents on the Stability of Sodium Tetradecyl Sulfate (STS) Foam: An Experimental Study.
    Hashimoto K; Uchida B; Horikawa M; Mimura H; Farsad K
    Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1952-1957. PubMed ID: 30088060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability.
    Chen AW; Liu YR; Li K; Liu SH
    Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.